Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 12/20 | 0.55 |
| ▸ | CES1 | P23141 | 10/20 | 0.55 |
| ▸ | CES2 | O00748 | 5/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.46 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.46 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | PPARD | Q03181 | 1/20 | 0.46 |
| ▸ | PPARA | Q07869 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6535994 | 1.00 | FAAH (0.55) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL20590786 | 1.00 | FAAH (0.55) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL723653 | 0.91 | FAAH (0.65) | FAAHCES1MEN1CYP1A2KMT2A | |
| SCHEMBL31299556 | 0.90 | FAAH (0.50) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL16116786 | 0.86 | KMT2A (0.52) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL116286 | 0.85 | FAAH (0.57) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL3047322 | 0.83 | FAAH (0.55) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL2462129 | 0.83 | FAAH (0.55) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL29109867 | 0.83 | FAAH (0.55) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL2460155 | 0.83 | FAAH (0.55) | FAAHCES1CES2MEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119015412-A | Nanometer photosensitizer and application thereof in echinococcosis | 兰州大学 | 2024-11-26 | — | — | CN | claimed |
| EP-4004548-B1 | METHODS OF TREATING AND DIAGNOSING LUNG CANCER | YEDA RES & DEV (IL) | 2026-01-14 | — | — | EP | disclosed |
| US-20250354993-A1 | METHODS OF TREATING AND DIAGNOSING LUNG CANCER | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2025-11-20 | — | — | US | disclosed |
| EP-4622629-A1 | METHOD FOR TREATING AND/OR PREVENTING EDEMATOUS FIBROSCLEROTIC PANNICULOPATHY | Caliway Biopharmaceuticals Co. Ltd. (TW) | 2025-10-01 | — | — | EP | disclosed |
| CN-119015412-A | Nanometer photosensitizer and application thereof in echinococcosis | 兰州大学 | 2024-11-26 | — | — | CN | disclosed |
| WO-2024109276-A1 | METHOD FOR TREATING AND/OR PREVENTING EDEMATOUS FIBROSCLEROTIC PANNICULOPATHY | CALIWAY BIOPHARMACEUTICALS CO., LTD. (CN) | 2024-05-30 | — | — | WO | disclosed |
| US-20240165050-A1 | METHOD FOR TREATING AND/OR PREVENTING EDEMATOUS FIBROSCLEROTIC PANNICULOPATHY | CALIWAY BIOPHARMACEUTICALS CO., LTD. (TW) | 2024-05-23 | — | — | US | disclosed |
| US-20240009315-A1 | METHODS OF TARGETING AGENTS TO ACE2 RECEPTORS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2024-01-11 | — | — | US | disclosed |
| US-11865184-B2 | Method of targeting senescent cells | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2024-01-09 | — | — | US | disclosed |
| CN-116271078-A | Synthesis method of targeted drug nCoVshRNA.2ACE2 | 杭州痴创生物科技有限公司 | 2023-06-23 | — | — | CN | disclosed |
| US-6210707-B1 | LIPID:NUCLEIC ACID COMPLEXES THAT HAVE INCREASED SHELF LIFE AND HIGH TRANSFECTION ACTIVITY IN VIVO | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2001-04-03 | — | — | US | disclosed |
| EP-1078079-A1 | METHODS OF FORMING PROTEIN-LINKED LIPIDIC MICROPARTICLES, AND COMPOSITIONS THEREOF | The Regents of the University of California (US) | 2001-02-28 | — | — | EP | disclosed |
| US-6071533-A | Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-06-06 | — | — | US | disclosed |
| EP-0912198-A4 | IMMUNOLIPOSOMES THAT OPTIMIZE INTERNALIZATION INTO TARGET CELLS | UNIV CALIFORNIA (US) | 2000-04-12 | — | — | EP | disclosed |
| WO-1999058694-A1 | METHODS OF FORMING PROTEIN-LINKED LIPIDIC MICROPARTICLES, AND COMPOSITIONS THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1999-11-18 | — | — | WO | disclosed |
| EP-0956001-A1 | PREPARATION OF STABLE FORMULATIONS OF LIPID-NUCLEIC ACID COMPLEXES FOR EFFICIENT $i(IN VIVO) DELIVERY | The Regents of the University of California (US) | 1999-11-17 | — | — | EP | disclosed |
| EP-0912198-A1 | IMMUNOLIPOSOMES THAT OPTIMIZE INTERNALIZATION INTO TARGET CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1999-05-06 | — | — | EP | disclosed |
| WO-1998020857-A1 | PREPARATION OF STABLE FORMULATIONS OF LIPID-NUCLEIC ACID COMPLEXES FOR EFFICIENT IN VIVO DELIVERY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-05-22 | — | — | WO | disclosed |
| WO-1997038731-A1 | IMMUNOLIPOSOMES THAT OPTIMIZE INTERNALIZATION INTO TARGET CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-10-23 | — | — | WO | disclosed |
| WO-1996014864-A1 | IMMUNOLIPOSOMES THAT OPTIMIZE INTERNALIZATION INTO TARGET CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1996-05-23 | — | — | WO | disclosed |